Eva-Maria Didden

Johnson & Johnson, Switzerland

Poster(s):

• ((A-202)) (A-202) Active Safety Surveillance Using Real-world Evidence (ASSURE) Implementation: Transparent and Reproducible Real-World Evidence (RWE) Standardized Framework to Support Safety Signal Evaluation
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• ((B-203)) (B-203) Aggregating and harmonizing registry databases for comparative analyses – lessons learnt
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• ((C-027)) (C-027) Considerations for estimating prevalence and incidence based on systematic literature review: an example in geographic atrophy
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• ((C-075)) (C-075) Evaluating treatment patterns in newly diagnosed Pulmonary Arterial Hypertension patients: First network study in PHederation, the Pulmonary Hypertension federated data network
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• ((C-117)) (C-117) Feasibility assessments in federated networks of disease-specific harmonized data assets: best-practice recommendations based on the PHederation experience
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• ((C-222)) (C-222) Incidence of second primary T-cell non-Hodgkin lymphoma among multiple myeloma patients: evidence from real-world data
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET